Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiarrhythmic Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN109053652A offers high-purity Amiodarone intermediate synthesis with improved yield and scalability for global supply chains.
Patent CN102603591B details a novel route for Vernakalant intermediates. Offers mild conditions, high optical purity, and scalable supply chain solutions for global procurement.
Discover the green synthesis of Amiodarone Hydrochloride via Lewis acid catalysis. This patent offers cost reduction in API manufacturing and high-purity intermediates.